These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11789829)

  • 1. The antithrombotic and antiinflammatory mechanisms of action of aprotinin.
    Landis RC; Asimakopoulos G; Poullis M; Haskard DO; Taylor KM
    Ann Thorac Surg; 2001 Dec; 72(6):2169-75. PubMed ID: 11789829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New antiinflammatory and platelet-preserving effects of aprotinin.
    Landis RC; Haskard DO; Taylor KM
    Ann Thorac Surg; 2001 Nov; 72(5):S1808-13. PubMed ID: 11722114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgery.
    Landis RC; Asimakopoulos G; Poullis M; Thompson R; Nourshargh S; Haskard DO; Taylor KM
    Heart Surg Forum; 2001; 4 Suppl 1():S35-9. PubMed ID: 11178306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial investigating the relationship between aprotinin and hypercoagulability in off-pump coronary surgery.
    Desai PH; Kurian D; Thirumavalavan N; Desai SP; Ziu P; Grant M; White C; Landis RC; Poston RS
    Anesth Analg; 2009 Nov; 109(5):1387-94. PubMed ID: 19843776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aprotinin: is it prothrombotic?
    Poullis M; Landis RC; Taylor KM
    Perfusion; 2001 Sep; 16(5):401-9. PubMed ID: 11565895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprotinin: antifibrinolytic and anti-inflammatory mechanisms of action in cardiac surgery with cardiopulmonary bypass.
    Donahue MA; Price PM
    Dynamics; 2002; 13(3):16-23. PubMed ID: 12640841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.
    Alderman EL; Levy JH; Rich JB; Nili M; Vidne B; Schaff H; Uretzky G; Pettersson G; Thiis JJ; Hantler CB; Chaitman B; Nadel A
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):716-30. PubMed ID: 9806378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aprotinin.
    Robert S; Wagner BK; Boulanger M; Richer M
    Ann Pharmacother; 1996 Apr; 30(4):372-80. PubMed ID: 8729892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action.
    McEvoy MD; Reeves ST; Reves JG; Spinale FG
    Anesth Analg; 2007 Oct; 105(4):949-62. PubMed ID: 17898372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1.
    Poullis M; Manning R; Laffan M; Haskard DO; Taylor KM; Landis RC
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):370-8. PubMed ID: 10917956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery.
    Peters DC; Noble S
    Drugs; 1999 Feb; 57(2):233-60. PubMed ID: 10188764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin in cardiac surgery.
    Sodha NR; Boodhwani M; Bianchi C; Ramlawi B; Sellke FW
    Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):151-60. PubMed ID: 16509811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass.
    Wahba A; Black G; Koksch M; Rothe G; Preuner J; Schmitz G; Birnbaum DE
    Thromb Haemost; 1996 May; 75(5):844-8. PubMed ID: 8725734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin: a pharmacologic overview.
    Levy JH; Sypniewski E
    Orthopedics; 2004 Jun; 27(6 Suppl):s653-8. PubMed ID: 15239552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation.
    Day JR; Haskard DO; Taylor KM; Landis RC
    Ann Thorac Surg; 2006 Feb; 81(2):619-24. PubMed ID: 16427862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic inflammation and cardiac surgery: an update.
    Asimakopoulos G
    Perfusion; 2001 Sep; 16(5):353-60. PubMed ID: 11565890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why thrombin PAR1 receptors are important to the cardiac surgical patient.
    Landis C
    J Extra Corpor Technol; 2007 Dec; 39(4):305-7. PubMed ID: 18293826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease activated receptors: clinical relevance to hemostasis and inflammation.
    Landis RC
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):103-13. PubMed ID: 17258121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.